339 NOVEL LIPOSOMAL GEL OF AN ANTI-INFLAMMATORY AGENT: RANDOMIZED, DOUBLE-BLIND CLINICAL TRIAL FOR EVALUATION OF THE EFFICACY AND SAFETY IN PATIENTSWITH SIGNS AND SYMPTOMS OF OSTEOARTHRITIS OF THE KNEES

s Thirty-Ninth Annual Meeting American College of Clinical Pharmacology September 12-14, 2010 Baltimore, Maryland SAGE Publications J Clin Pharmacol 2010 50: 1058 DOI: 10.1177/0091270009379561 The online version of this article can be found at: http://jcp.sagepub.com/content/50/9/1058